GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · IEX Real-Time Price · USD
31.83
-0.79 (-2.42%)
At close: Jul 19, 2024, 4:00 PM
31.85
+0.02 (0.06%)
Pre-market: Jul 22, 2024, 7:43 AM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $832.38 million as of July 22, 2024. Its market cap has increased by 488.26% in one year.
Market Cap
832.38M
Enterprise Value
837.84M
1-Year Change
488.26%
Ranking
Category
Stock Price
$31.83
Market Cap Chart
Since September 2, 2020, GeneDx Holdings's market cap has increased from $448.40M to $832.38M, an increase of 85.63%. That is a compound annual growth rate of 17.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 832.10M | 1,068.68% |
| Dec 29, 2023 | 71.20M | -30.20% |
| Dec 30, 2022 | 102.00M | -90.52% |
| Dec 31, 2021 | 1.08B | 76.10% |
| Dec 31, 2020 | 611.00M | 36.26% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harrow Health | 884.90M |
| AbCellera Biologics | 873.34M |
| Perspective Therapeutics | 852.32M |
| Liquidia | 846.66M |
| Healthcare Services Group | 846.20M |
| InnovAge Holding | 825.45M |
| Mesoblast | 825.11M |
| Cogent Biosciences | 823.23M |